FASLG and hepatocellular carcinoma: In vitro studies suggested that extracellular AFP could affect the expression of certain oncogenes and the activation of Fas receptor-Fas ligand (FasL) signaling pathway, shielding HCC cells from apoptosis or allowing escape from immune surveillance21,22,24.